2 Minute Medicine Rewind August 9 – August 16, 2015
Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality Ankylosing spondylitis (AS) is a chronic inflammatory arthritis that affects, ...
Tag: multiple myeloma
Use of elotuzumab with conventional therapy linked to improved survival in multiple myeloma patients
1. Adding elotuzumab to the conventional lenalidomide and dezamethasone was associated with a 30% reduction in the risk of disease ...
Patient Basics: Multiple Myeloma
Originally published by Harvard Health. What Is It? Multiple myeloma is cancer of the bone marrow caused by the uncontrolled ...
2 Minute Medicine Rewind September 1 – September 8, 2014
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Use ...
FIRST trial: Lenalidomide with dexamethasone beats standard chemotherapy for multiple myeloma
1. Progression-free survival was improved by about 3 months with continuous lenalidomide-dexamethasone compared to standard melphalan-prednisone-thalidomide. 2. Overall survival was ...
Continued post-transplant response predicts improved prognosis in multiple myeloma
Image: PD RANKL protein structure 1. Continued monoclonal protein response to autologous stem cell transplantation (ASCT) is associated with improved ...
2 Minute Medicine Rewind July 29 – August 4, 2013
In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the past week. ...
Phase III trial shows survival benefit for early multiple myeloma
Image: CC/Osaro 1. Treatment with lenalidomide and dexamethasone significantly delayed disease progression in patients with smoldering multiple myeloma who were ...